Participants 19 41 3
venous thromboembolism
Participants 44 198 7
Patients with pulmonary embolism or deep venous thrombosis were randomly assigned to receive either intermittent or continuous intravenous heparin therapy
Participants 203 463 5
patients with an enhanced risk of bleeding, major bleeding was significantly more common during the intermittent use of heparin; in patients without these risk factors, hemorrhage occurred with equal frequency during intermittent and continuous heparin therapy
Participants 1425 1462 3
patients with a high risk of bleeding
